Keyphrases
Activin
100%
Anti-angiogenesis
100%
Antiangiogenesis Therapy
100%
Bevacizumab
80%
Bipotent
20%
Endothelial Cell Apoptosis
20%
Endothelial-to-mesenchymal Transition (EndMT)
20%
Glioblastoma
60%
Glioblastoma Cells
100%
Hyperpermeability
20%
Hypovascular
20%
Hypoxic Zone
20%
Inhibitor of Differentiation 1
40%
Mouse Model
20%
Prolonged Exposure
20%
SB431542
20%
Smad2
20%
Smad3
20%
Tumor
20%
Tumorigenesis
20%
Valuable Insight
20%
Vasculature
100%
Biochemistry, Genetics and Molecular Biology
Activin
100%
Antiangiogenic Activity
100%
Bevacizumab
80%
Carcinogenesis
20%
Cytokine
20%
Inhibitor of Differentiation 1
40%
Lead Poisoning
20%
Mouse Model
20%
Vascularization
100%
Immunology and Microbiology
Activin
100%
Activin A
40%
Antiangiogenic Activity
100%
Bevacizumab
80%
Cytokine
20%
Inhibitor of Differentiation 1
40%
Mouse Model
20%
Vascularization
100%
Neuroscience
Activin
100%
Activin A
40%
Angiogenesis
100%
Bevacizumab
80%
Carcinogenesis
20%
Inhibitor of Differentiation 1
40%
Pharmacology, Toxicology and Pharmaceutical Science